An emotional health update announcing approval of gene therapy as a treatment option for a medical condition ...

The FDA's decision follows data from a Phase Ib study on salanersen.

Belite Bio has completed its rolling NDA submission to the FDA for tinlarebant, a potential first approved treatment for ...

A study evaluating a pioneering lentivirus (LV)-mediated gene therapy trial for classical Fabry disease showed promising results over five years, indicating a potential breakthrough in treatment for ...

Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...

Breakthrough Therapy and RMAT designations can be powerful accelerators in oncology development, but their value depends on ...

A single jab of a breakthrough gene therapy could reverse hearing loss in people within weeks, according to new research. The cutting-edge therapy improved hearing in children and adults with ...

Vertex Pharmaceuticals' (NASDAQ: VRTX) stock price is up, but its Casgevy sales partner, CRISPR Therapeutics (NASDAQ: CRSP), is the real buy for long-term investors. Shares of Vertex, a biotech based ...

A breakthrough targeted therapy, mirvetuximab soravtansine, is offering new hope to women with hard-to-treat ovarian cancer. Studies show it extends survival, slows disease progression, shrinks ...

Suffolk County practice expands Teen Therapy, Teenagers Therapy, and Adults Therapy services to meet rising mental ...

At Breakthrough Therapy and Resources, we provide clinical support for individuals experiencing distress due to various life experiences. Utilizing a range of therapeutic interventions, we offer ...